Home » Topics » BioWorld Science

BioWorld Science
RSS

Abide Therapeutics discovers MGL and ABHD6 inhibitors

April 5, 2018

Pliant Therapeutics patents new integrin alphavbeta1 antagonists

April 5, 2018

A*STAR identifies novel MSP receptor-targeting antibodies

April 5, 2018

Kymera and GSK collaborate to accelerate discovery of protein-degrading therapeutics

April 5, 2018

Lilly and Sigilon collaborate on encapsulated cell therapies for type 1 diabetes

April 5, 2018

Novel gene fusion detected in BCR-ABL-negative leukemia

April 5, 2018

FDA allows IND for phase Ib/IIa study of AG-019 for early onset type 1 diabetes

April 5, 2018

FDA grants priority review to NDAs for omadacycline for CABP and ABSSSI

April 5, 2018

FDA grants orphan drug designation for MAX-40279 for the treatment of AML

April 5, 2018

PELP-1 mediates adverse response to endocrine therapy for ER-positive breast cancer

April 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...